Neurocrine Biosciences
NBIX
NBIX
125 hedge funds and large institutions have $1.05B invested in Neurocrine Biosciences in 2014 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 47 increasing their positions, 40 reducing their positions, and 13 closing their positions.
Holders
125
Holders Change
+4
Holders Change %
+3.31%
% of All Funds
3.6%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
17
Increased
47
Reduced
40
Closed
13
Calls
$10M
Puts
$7M
Net Calls
+$3.01M
Net Calls Change
-$355K
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
126
Envestnet Asset Management
Chicago,
Illinois
| $1K | – | – | – |
|
127
JPMorgan Chase & Co
New York
| – | -$2.26M | -140,449 | Closed |
|
128
Adage Capital Partners
Boston,
Massachusetts
| – | -$2.19M | -136,286 | Closed |
|
|
HCMT
129
Highland Capital Management (Texas)
Dallas,
Texas
| – | -$1.29M | -80,000 | Closed |
|
|
SB
130
Suntrust Banks
Atlanta,
Georgia
| – | -$1.11M | -68,757 | Closed |
|
|
3NC
131
300 North Capital
Pasadena,
California
| – | -$824K | -51,189 | Closed |
|
|
HI
132
HBK Investments
Dallas,
Texas
| – | -$749K | -46,500 | Closed |
|
|
DY
133
Dowling & Yahnke
San Diego,
California
| – | -$483K | -30,000 | Closed |
|
|
SCM
134
Sterling Capital Management
Charlotte,
North Carolina
| – | -$300K | -18,625 | Closed |
|
|
TC
135
TFS Capital
West Chester,
Pennsylvania
| – | -$163K | -10,131 | Closed |
|
|
BJ
136
BlackRock Japan
Tokyo,
Japan
| – | -$13K | -793 | Closed |
|
|
TRCT
137
Tower Research Capital (TRC)
New York
| – | -$10K | -618 | Closed |
|
138
Creative Planning
Overland Park,
Kansas
| – | -$8K | -500 | Closed |
|
139
M&T Bank
Buffalo,
New York
| – | -$1K | -61 | Closed |
|